Serum p53 antibodies in patients with lung cancer: correlation with clinicopathologic features and smoking

Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6

Elisheva Yonish-Rouach, Dalia Resnftzky, Joseph Lotem et al. · Nature · 1991 · 2.1K citations

Medicine, Hematology, Oncology +13

Preferential Formation of Benzo[ <i>a</i> ]pyrene Adducts at Lung Cancer Mutational Hotspots in <i>P53</i>

Mikhail F. Denissenko, Annie Pao, Moon‐shong Tang et al. · Science · 1996 · 1.7K citations

Medicine, Genetics, Molecular Biology +17

Serum p53 antibodies as early markers of lung cancer

Richard Lubin, Gérard Zalcman, Laurence Bouchet et al. · Nature Medicine · 1995 · 330 citations

Medicine, Oncology, Pathology +16

A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression.

David H. Harpole, J E Herndon, Walter G. Wolfe et al. · PubMed · 1995 · 293 citations

Medicine, Oncology, Pathology +17

Prevalence of serum antibodies against the p53 tumor suppressor gene protein in various cancers

Katerina Angelopoulou, Eleftherios P. Diamandis, D. J. Sutherland et al. · International Journal of Cancer · 1994 · 222 citations

Medicine, Immunology, Oncology +11